Fragment 176-191 & CJC-1295 & Ipamorelin Blend

This triple peptide blend combines Fragment 176-191 (6mg), CJC-1295 (3mg), and Ipamorelin (3mg) for synergistic effects on growth hormone release and metabolism. Fragment 176-191 targets fat cells via β3-AR, while CJC-1295 and Ipamorelin stimulate pituitary GH release via GHRH and ghrelin receptors respectively. Research indicates applications in body composition, fat metabolism, and tissue regeneration.